| Syrah Resources Limited (SYR) ORDINARY FULLY PAID |
Materials |
$308 |
December 2024 Quarterly Activities Presentation
|
30 Jan 2025 9:21AM |
$0.230 |
$0.235 |
risen by
2.17%
|
|
SYR - Price-sensitive ASX Announcement
Full Release
Key Points
- No production at Balama due to protest actions impeding operations
- Syrah declared force majeure at Balama
- Achieved Initiative for Responsible Mining Assurance 50 level of performance for Balama
- Lower natural graphite sales due to a significantly higher proportion of lower priced fines in the sales mix
- Balama natural graphite inventory depleted to 2kt
- Production at Vidalia related only to AAM qualification processes
- Continued progress in Vidalia AAM qualification processes with customers
- Vidalia AAM sales expected this year, with timing dependent on qualification progress and market conditions
- Quarter end cash balance of US$87m, including US$58m restricted cash
- Syrah awarded US$165 million Section 48C tax credit for the Vidalia Further Expansion project
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AUCyber Limited (CYB) ORDINARY FULLY PAID |
Information Technology |
$15 |
Change in substantial holding from 5GN
|
30 Jan 2025 9:21AM |
$0.135 |
$0.073 |
fallen by
45.93%
|
|
| 5G Networks Limited (5GN) ORDINARY FULLY PAID |
Information Technology |
$35 |
Change in substantial holding for CYB
|
30 Jan 2025 9:21AM |
$0.160 |
$0.130 |
fallen by
18.75%
|
|
| Tryptamine Therapeutics Limited (TYP) ORDINARY FULLY PAID |
Health Care |
- |
Quarterly Activities Report and Appendix 4C
|
30 Jan 2025 9:21AM |
$0.031 |
$0.034 |
risen by
9.68%
|
|
TYP - Price-sensitive ASX Announcement
Full Release
Key Points
- TRP-8803 completion of Phase 1b study showing safety and tolerability.
- Interim analysis of Phase 2a IBS study showed 75% patient pain reduction.
- Raised $6 million from new and existing investors.
- Cash at bank was $2.8 million as of December 31, 2024.
- Company positioned to advance clinical trials in 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Godolphin Resources Limited (GRL) ORDINARY FULLY PAID |
Materials |
$25 |
Up to 42.7m Sulphide Mineralisation Intersected Lewis Ponds
|
30 Jan 2025 9:20AM |
$0.014 |
$0.035 |
risen by
150%
|
|
GRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Four drill holes totaling 1,094.8m have been drilled at the Lewis Ponds Project.
- Final two drill holes intersected further encouraging base metal mineralisation.
- GLPDD008 intersected 20.25m of massive, semi-massive and disseminated sulphide mineralisation.
- GLPDD009 intersected 42.7m of massive, semi-massive and disseminated sulphide mineralisation.
- Existing JORC 2012 Inferred Resource of 6.20 Mt at 2.0g/t gold, 80g/t silver, 2.7% zinc, 1.6% lead and 0.2% copper.
- Assay results from drill holes GLPDD006 and GLPDD007 are expected soon.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| A1 Investments & Resources Ltd (AYI) ORDINARY FULLY PAID |
Financials |
- |
Appendix 4C
|
30 Jan 2025 9:20AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Alterity Therapeutics Limited (ATH) ORDINARY FULLY PAID |
Health Care |
$76 |
Positive ATH434 Phase 2 Results Led By Clinical Efficacy
|
30 Jan 2025 9:20AM |
$0.008 |
$0.007 |
fallen by
12.50%
|
|
ATH - Price-sensitive ASX Announcement
Full Release
Key Points
- ATH434 Phase 2 trial showed significant slowing of clinical progression in MSA.
- The 50 mg dose achieved a 48% reduction in clinical decline.
- Robust MRI biomarker results indicated iron stabilization in key brain areas.
- ATH434 was well-tolerated with no serious adverse events related to the drug.
- The study involved 77 participants across 23 global sites.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OpenLearning Limited (OLL) ORDINARY FULLY PAID |
Information Technology |
$28 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2025 9:19AM |
$0.019 |
$0.036 |
risen by
89.47%
|
|
OLL - Price-sensitive ASX Announcement
Full Release
Key Points
- Platform SaaS annual recurring revenue grew 23% YoY to $2.335 million in Q4 FY24.
- Average revenue per B2B SaaS customer increased 17% YoY to $9,767 per annum.
- Cash receipts from customers rose 45% YoY to $1.084 million.
- Net operating cash outflows decreased by 52% YoY to $0.365 million.
- CourseMagic.ai gained 126 active B2C customers and contributed to SaaS revenue growth.
- The company signed its first higher education customers through a partnership with Meshed Group.
- OpenLearning is expanding into international student recruitment via The Uni Guide.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tesoro Gold Ltd (TSO) ORDINARY FULLY PAID |
Materials |
$214 |
Quarterly Cashflow Report
|
30 Jan 2025 9:19AM |
$0.022 |
$1.205 |
risen by
5,377.27%
|
|
TSO - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash from operating activities was negative at $100,000.
- Exploration and evaluation costs amounted to $2.8 million.
- Ending cash and cash equivalents were reported at $3.86 million.
- The estimated available quarters of funding is approximately 1.31.
- The company expects to continue operations and achieve business objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GTI Energy Ltd (GTR) ORDINARY FULLY PAID |
Materials |
- |
Two Water Wells Completed & Staking Finalised at Lo Herma
|
30 Jan 2025 9:19AM |
$0.003 |
$0.130 |
risen by
4,233.33%
|
|
GTR - Price-sensitive ASX Announcement
Full Release
Key Points
- Two groundwater monitoring wells drilled and completed
- Drilling of third groundwater monitoring well in progress
- Staking of additional claims finalised
- Performance Rights vested following successful resource upgrade
- Groundwater monitoring holes will facilitate testing of hydraulic parameters
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nexion Group Ltd (NNG) ORDINARY FULLY PAID |
Information Technology |
$4 |
NNG Quarterly Activities Report and Appendix 4C Dec-24
|
30 Jan 2025 9:19AM |
$0.020 |
$0.020 |
fallen by
0%
|
|
| Tivan Limited (TVN) ORDINARY FULLY PAID |
Materials |
$836 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2025 9:19AM |
$0.113 |
$0.370 |
risen by
228.89%
|
|
TVN - Price-sensitive ASX Announcement
Full Release
Key Points
- Commencement of ground-disturbing works at the Speewah Fluorite Project.
- Speewah Fluorite Project awarded Major Project Status.
- Received a $7.4 million cash grant under the IPCM Program.
- MoU signed with Sumitomo Corporation for a joint venture.
- Regulatory approval secured for drilling at the Sandover AI Project.
- Mineral Exploration Deeds secured with Central Land Council for Sandover Project.
- High-grade fluorite assays returned from Sandover Fluorite Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Marmota Limited (MEU) ORDINARY FULLY PAID |
Energy |
$177 |
Trading Halt
|
30 Jan 2025 9:18AM |
$0.063 |
$0.150 |
risen by
138.10%
|
|
MEU - Price-sensitive ASX Announcement
Full Release
Key Points
- Marmota Limited requested a trading halt for its securities.
- The halt is pending an announcement regarding capital raising.
- The trading halt will last until February 3, 2025, or until the announcement is made.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$31 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2025 9:18AM |
$0.018 |
$0.038 |
risen by
111.11%
|
|
AT1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Atomo secures an order worth $440k for supply of HIV Self-Tests in Australia.
- Atomo executes a $2.44M CRC-P Grant with the Australian Federal Government.
- Total revenue of $1.2m for Q2 FY25, bringing total H1 revenue to ~$2.1m.
- Cash receipts from customers during the quarter were $1.7m.
- Atomo continues to see growth in its HIV Self-Test business.
- The company has onboarded 41 new pharmacies in Australia.
- Atomo is developing a novel rapid test for syphilis.
- Atomo finished the quarter debt-free with cash on hand of $2.9m.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$36 |
Positive DSMB Safety Outcome & Phase 2 Trial Progress Update
|
30 Jan 2025 9:17AM |
$0.655 |
$0.280 |
fallen by
57.25%
|
|
AGN - Price-sensitive ASX Announcement
Full Release
Key Points
- DSMB reviewed safety data of 76 patients and recommends trial continuation.
- This marks the final DSMB review for the Phase 2 trial.
- 79 patients have been dosed, indicating an 86% completion of patient dosing.
- The trial anticipates completion of dosing by early Q2 CY2025.
- Argentica is developing ARG-007 to reduce brain tissue death post-stroke.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IGO Limited (IGO) ORDINARY FULLY PAID |
Materials |
$6,300 |
2Q25 Results Presentation
|
30 Jan 2025 9:17AM |
$5.150 |
$8.320 |
risen by
61.55%
|
|
| Great Divide Mining Ltd (GDM) ORDINARY FULLY PAID |
Materials |
$19 |
LiDAR Identifies Multiple New Gold Targets - Devils Mountain
|
30 Jan 2025 9:17AM |
$0.320 |
$0.380 |
risen by
18.75%
|
|
GDM - Price-sensitive ASX Announcement
Full Release
Key Points
- GDM completed a LiDAR interpretation at its Devils Mountain Gold Project.
- The Gympie 2023 LiDAR dataset covers 44 km2.
- 204 historical mine workings were identified, including previously unknown shafts and adits.
- The LiDAR analysis enhances GDM's dataset for identifying gold targets.
- The results confirm GDM’s strategy of targeting historical mining areas.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resource Minerals International Ltd (RMI) ORDINARY FULLY PAID |
Materials |
$24 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2025 9:16AM |
$0.006 |
$0.028 |
risen by
366.67%
|
|
RMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Mpanda and Mbozi copper-gold projects are highly prospective.
- Drilling confirms the presence of anomalous Au and Cu values.
- Company secured $1 million loan funding.
- RMI entered an option to acquire a 70% interest in a Saudi Arabia gold project.
- Report emphasizes the strategic intent to enhance shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Viridis Mining and Minerals Limited (VMM) ORDINARY FULLY PAID |
Materials |
$201 |
Trading Halt
|
30 Jan 2025 9:16AM |
$0.395 |
$1.810 |
risen by
358.23%
|
|
VMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Viridis Mining and Minerals Limited requests a trading halt.
- The halt is pending the release of an announcement regarding a capital raising.
- The trading halt is effective immediately.
- The halt is expected to last until 3 February 2025 or until the announcement is released.
- VMM confirms no reason exists for the halt not to be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$14 |
Proposed issue of securities - LSR
|
30 Jan 2025 9:15AM |
$0.014 |
$0.012 |
fallen by
14.29%
|
|
| Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$14 |
Proposed issue of securities - LSR
|
30 Jan 2025 9:15AM |
$0.014 |
$0.012 |
fallen by
14.29%
|
|
| Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$14 |
Proposed issue of securities - LSR
|
30 Jan 2025 9:15AM |
$0.014 |
$0.012 |
fallen by
14.29%
|
|
| Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$14 |
Placement
|
30 Jan 2025 9:15AM |
$0.014 |
$0.012 |
fallen by
14.29%
|
|
LSR - Price-sensitive ASX Announcement
Full Release
Key Points
- Lodestar completes $520,000 fundraising
- Placement managed by Liquidity
- 47,272,727 shares issued at 1.1 cents per share
- Funds to advance exploration programs
- Inaugural RC drilling at the Darwin project in Chile
- Includes 8,500,000 attaching options subject to approval
- Directors will also participate in the placement
- Use of funds allocated for drilling, projects, and working capital
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Syrah Resources Limited (SYR) ORDINARY FULLY PAID |
Materials |
$308 |
December 2024 Quarterly Activities and Cashflow Report
|
30 Jan 2025 9:15AM |
$0.230 |
$0.235 |
risen by
2.17%
|
|
SYR - Price-sensitive ASX Announcement
Full Release
Key Points
- Syrah achieved an IRMA 50 performance level for responsible mining.
- The cash balance as of December 31, 2024, was US$87 million.
- Low sales impacted net cash flow from operating activities.
- Syrah is in discussions with nine customers for multi-year AAM supply agreements.
- The facility in Vidalia is currently focused on qualification processes due to uncertainties in customer demand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurum Resource Limited (AUE) ORDINARY FULLY PAID |
Materials |
$224 |
Aurum hits 150 g/t gold at Boundiali, Cote d'Ivoire
|
30 Jan 2025 9:14AM |
$0.260 |
$0.645 |
risen by
148.08%
|
|
AUE - Price-sensitive ASX Announcement
Full Release
Key Points
- Aurum hits 150 g/t gold at Boundiali.
- Reports high-grade gold intercepts from 1.59Moz Boundiali Gold Project.
- Drilling results include 1m @ 150.50 g/t Au within 3m @ 50.56 g/t Au.
- Aurum plans 100,000m drilling campaign in CY2025.
- Two mineral resource estimate updates planned in CY2025.
- Aurum is well-funded with approximately $23 million cash.
- Takeover bid for Mako Gold moves to compulsory acquisition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
